These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

898 related items for PubMed ID: 16085959

  • 1. [Kawasaki disease in children--9 years experience].
    Kowalczyk M, Kawalec W, Daszkowska-York J, Turska-Kmieć A, Brzezińska-Rajszys G, Sobielarska D, Ziółkowska L, Kościesza A, Jagiełłowicz D, Mirecka-Rola A.
    Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
    [Abstract] [Full Text] [Related]

  • 2. Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect?
    Abushaban L, Salama A, Uthaman B, Kumar A, Selvan J.
    Int J Cardiol; 1999 Apr 30; 69(1):71-6. PubMed ID: 10362375
    [Abstract] [Full Text] [Related]

  • 3. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Apr 30; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 4. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
    J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
    [Abstract] [Full Text] [Related]

  • 5. Giant aneurysms: A gender-specific complication of Kawasaki disease?
    Dietz SM, Kuipers IM, Tacke CEA, Koole JCD, Hutten BA, Kuijpers TW.
    J Cardiol; 2017 Oct 15; 70(4):359-365. PubMed ID: 28325522
    [Abstract] [Full Text] [Related]

  • 6. Kawasaki disease in infants less than one year of age.
    Rosenfeld EA, Corydon KE, Shulman ST.
    J Pediatr; 1995 Apr 15; 126(4):524-9. PubMed ID: 7699529
    [Abstract] [Full Text] [Related]

  • 7. [Kawasaki disease: clinical characteristics and cardiovascular involvement in a cohort of 121 patients].
    Calabri GB, Falcini F, Favilli S, Pollini I, Capuzzo L, Simonini G, De Simone L.
    Pediatr Med Chir; 2002 Apr 15; 24(5):352-7; discussion 397-9. PubMed ID: 12494535
    [Abstract] [Full Text] [Related]

  • 8. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.
    Dionne A, Burns JC, Dahdah N, Tremoulet AH, Gauvreau K, de Ferranti SD, Baker AL, Son MB, Gould P, Fournier A, Newburger JW, Friedman KG.
    Pediatrics; 2019 Jun 15; 143(6):. PubMed ID: 31048414
    [Abstract] [Full Text] [Related]

  • 9. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
    Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, Fuse S, Hamaoka K, Hirono K, Kato T, Mitani Y, Sato S, Shimoyama S, Shiono J, Suda K, Suzuki H, Maeda J, Waki K, The Z-score Project 2nd Stage Study Group, Kato H, Saji T, Yamagishi H, Ozeki A, Tomotsune M, Yoshida M, Akazawa Y, Aso K, Doi S, Fukasawa Y, Furuno K, Hayabuchi Y, Hayashi M, Honda T, Horita N, Ikeda K, Ishii M, Iwashima S, Kamada M, Kaneko M, Katyama H, Kawamura Y, Kitagawa A, Komori A, Kuraishi K, Masuda H, Matsuda S, Matsuzaki S, Mii S, Miyamoto T, Moritou Y, Motoki N, Nagumo K, Nakamura T, Nishihara E, Nomura Y, Ogata S, Ohashi H, Okumura K, Omori D, Sano T, Suganuma E, Takahashi T, Takatsuki S, Takeda A, Terai M, Toyono M, Watanabe K, Watanabe M, Yamamoto M, Yamamura K.
    JAMA Pediatr; 2018 May 07; 172(5):e180030. PubMed ID: 29507955
    [Abstract] [Full Text] [Related]

  • 10. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
    Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM, Kahn R, Mossberg M, Kucera F, Tulloh R, Standing JF, Swallow V, McCormack R, Herberg J, Levin M, Wan M, Klein N, Connon R, Walker AS, Brogan P.
    Trials; 2023 Jan 26; 24(1):60. PubMed ID: 36703139
    [Abstract] [Full Text] [Related]

  • 11. [Six Kawasaki disease patients with acute coronary artery thrombosis].
    Zhou SL, Luo JP, Qi YQ, Liang YG, Wang W, Gong FQ.
    Zhonghua Er Ke Za Zhi; 2013 Dec 26; 51(12):925-9. PubMed ID: 24495764
    [Abstract] [Full Text] [Related]

  • 12. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J.
    Hosp Pediatr; 2014 Jul 26; 4(4):233-8. PubMed ID: 24986993
    [Abstract] [Full Text] [Related]

  • 13. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
    Michihata N, Matsui H, Fushimi K, Yasunaga H.
    Clin Pediatr (Phila); 2015 Oct 26; 54(11):1076-80. PubMed ID: 25573948
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
    Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, Romano A, Bierman FZ.
    Arch Pediatr Adolesc Med; 2006 Jul 26; 160(7):686-90. PubMed ID: 16818833
    [Abstract] [Full Text] [Related]

  • 15. Management of coronary artery aneurysms using abciximab in children with Kawasaki disease.
    Bachlava E, Loukopoulou S, Karanasios E, Chrousos G, Michos A.
    Int J Cardiol; 2016 Oct 01; 220():65-9. PubMed ID: 27372045
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Pediatrics; 2004 Dec 01; 114(6):1708-33. PubMed ID: 15574639
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, American Academy of Pediatrics.
    Circulation; 2004 Oct 26; 110(17):2747-71. PubMed ID: 15505111
    [Abstract] [Full Text] [Related]

  • 18. Kawasaki disease in Jordan: demographics, presentation, and outcome.
    Al-Ammouri I, Al-Wahsh S, Khuri-Bulos N.
    Cardiol Young; 2012 Aug 26; 22(4):390-5. PubMed ID: 22067065
    [Abstract] [Full Text] [Related]

  • 19. Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab.
    O'connor MJ, Saulsbury FT.
    Clin Pediatr (Phila); 2007 May 26; 46(4):345-8. PubMed ID: 17475994
    [Abstract] [Full Text] [Related]

  • 20. Risk factors associated with progression and persistence of small- and medium-sized coronary artery aneurysms in Kawasaki disease: a prospective cohort study.
    Liu L, Luo C, Hua Y, Wu M, Shao S, Liu X, Zhou K, Wang C.
    Eur J Pediatr; 2020 Jun 26; 179(6):891-900. PubMed ID: 31980953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.